| Item Type | Name |
|
Concept
|
Delivery of Health Care
|
|
Concept
|
Patient Acceptance of Health Care
|
|
Concept
|
Primary Health Care
|
|
Concept
|
Quality Assurance, Health Care
|
|
Concept
|
Quality of Health Care
|
|
Concept
|
Health Care Costs
|
|
Concept
|
Health Care Reform
|
|
Concept
|
Delivery of Health Care, Integrated
|
|
Concept
|
Health Care Surveys
|
|
Concept
|
Health Care Sector
|
|
Concept
|
Quality Indicators, Health Care
|
|
Concept
|
Healthcare Disparities
|
|
Academic Article
|
ACC/AHA/SCAI 2014 health policy statement on structured reporting for the cardiac catheterization laboratory: a report of the American College of Cardiology Clinical Quality Committee.
|
|
Concept
|
Administrative Claims, Healthcare
|
|
Academic Article
|
The risk of cardiovascular events in primary care patients following an episode of severe hypertension.
|
|
Academic Article
|
Safety gaps in medical team communication: Results of quality improvement efforts in a cardiac catheterization laboratory.
|
|
Academic Article
|
Recovery after resuscitation from cardiac arrest in ST-elevation myocardial infarction: a computer-based medical decision-support tool.
|
|
Academic Article
|
Physician stated atrial fibrillation management in light of treatment guidelines: data from an international, observational prospective survey.
|
|
Academic Article
|
Economic outcome of cardiac CT-based evaluation and standard of care for suspected acute coronary syndrome in the emergency department: a decision analytic model.
|
|
Academic Article
|
Patterns of warfarin use and subsequent outcomes in atrial fibrillation in primary care practices.
|
|
Academic Article
|
Public Reporting II: State of the Art-Current Public Reporting in Cardiovascular Medicine.
|
|
Academic Article
|
Task force #2--the cost of prevention: can we afford it? Can we afford not to do it? 33rd Bethesda Conference.
|
|
Academic Article
|
Determining patient utility following coronary revascularization.
|
|
Academic Article
|
Diagnosing coronary artery disease and cost of care.
|
|
Academic Article
|
The effect of a cardiovascular educational intervention on healthcare utilization and costs.
|
|
Academic Article
|
Trends in outcome and costs of coronary intervention in the 1990s.
|
|
Academic Article
|
Making Cardiovascular Care More Responsive to Societal Needs.
|
|
Academic Article
|
Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction.
|
|
Academic Article
|
Benchmarking cardiac catheterization laboratories: the impact of patient age, gender and risk factors on variable costs, device costs, total time and procedural time in 53 catheterization laboratories.
|
|
Academic Article
|
Patient health status and costs in heart failure: insights from the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS).
|
|
Academic Article
|
Racial Disparities in Clinical Characteristics and Outcomes of Women Undergoing Percutaneous Coronary Intervention.
|
|
Academic Article
|
Economic winners and losers after introduction of an effective new therapy depend on the type of payment system.
|
|
Academic Article
|
Evaluating the risk of coronary surgery and percutaneous coronary intervention.
|
|
Academic Article
|
Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States.
|
|
Academic Article
|
The impact of care management information technology model on quality of care after Coronary Artery Bypass Surgery: "Bridging the Divides".
|
|
Academic Article
|
Patterns and outcomes of drug-eluting coronary stent use in clinical practice.
|
|
Academic Article
|
Coronary surgery, ethnic origin, and value in health care.
|
|
Academic Article
|
Is cardiac catheterization necessary before initial management of patients with stable ischemic heart disease? Results from a Web-based survey of cardiologists.
|
|
Academic Article
|
The limits of cost-effectiveness analysis.
|
|
Academic Article
|
Measurement of health status after transmyocardial laser revascularization: critical but not the final answer.
|
|
Academic Article
|
Explaining racial disparities in coronary outcomes in women.
|
|
Academic Article
|
Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromes.
|
|
Academic Article
|
Reduced heart?failure-related healthcare costs with Furoscix versus in-hospital intravenous diuresis in heart failure?patients: the FREEDOM-HF study.
|
|
Academic Article
|
Comparison of recovery after mitral valve repair and replacement.
|
|
Academic Article
|
The Economic Burden of Illness.
|
|
Academic Article
|
Task Force on Strategic Research Direction: Population/Outcomes/Epidemiology/Social Science Subgroup key science topics report.
|
|
Academic Article
|
Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.
|
|
Academic Article
|
Outpatient percutaneous coronary interventions: hospital and health system costs saving while maintaining patient safety.
|
|
Academic Article
|
Time course of depression and outcome of myocardial infarction.
|
|
Academic Article
|
Editorial: Incidence, disparities and outcome of acute coronary syndromes: Implications for health care systems.
|
|
Academic Article
|
Public Reporting III: Improving the Value of Public Physician Quality Information.
|
|
Academic Article
|
Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control.
|
|
Academic Article
|
Cost-effectiveness of eplerenone in patients with left ventricular dysfunction after myocardial infarction--an analysis of the EPHESUS study from a Swiss perspective.
|
|
Academic Article
|
Clinical and Economic Outcomes of Ranolazine Versus Conventional Antianginals Users Among Veterans With Chronic Stable Angina Pectoris.
|
|
Academic Article
|
Annual Cost of Implementing Intensive Systolic Blood Pressure Goals in the United States.
|
|
Academic Article
|
From chest pain to coronary functional testing: Clinical and economic impact of coronary microvascular dysfunction.
|
|
Academic Article
|
Can cardiovascular clinical characteristics be identified and outcome models be developed from an in-patient claims database?
|
|
Academic Article
|
Timing of staged percutaneous coronary intervention in multivessel coronary artery disease.
|
|
Academic Article
|
An introduction to clinical microeconomic analysis: purposes and analytic methods.
|
|
Academic Article
|
2016 ACC/ASE/ASNC/HRS/SCAI Health Policy Statement on Integrating the Healthcare Enterprise.
|
|
Academic Article
|
Clinical prediction model suitable for assessing hospital quality for patients undergoing carotid endarterectomy.
|
|
Academic Article
|
Controversies and opportunities in economic analysis of health care.
|
|
Academic Article
|
Establishing a pragmatic framework to optimise health outcomes in heart failure and multimorbidity (ARISE-HF): A multidisciplinary position statement.
|
|
Academic Article
|
Reduced 6-month resource use and costs associated with cilostazol in patients after successful coronary stent implantation: results from the Cilostazol for RESTenosis (CREST) trial.
|
|
Academic Article
|
The Rising Urgency to Pivot Back Toward Hippocratic Medicine.
|
|
Academic Article
|
Report of the National Heart, Lung, and Blood Institute working group on outcomes research in cardiovascular disease.
|
|
Academic Article
|
Evaluating the cost of therapy for restenosis: considerations for brachytherapy.
|
|
Academic Article
|
On- versus off-label use of drug-eluting coronary stents in clinical practice (report from the American College of Cardiology National Cardiovascular Data Registry [NCDR]).
|
|
Academic Article
|
The changing healthcare market: outlook for the future of cardiovascular disease treatment--Part 2.
|
|
Academic Article
|
Our social contract to offer optimum percutaneous coronary intervention.
|
|
Academic Article
|
Fondaparinux versus Enoxaparin in non-ST-elevation acute coronary syndromes: short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial.
|
|
Academic Article
|
Technological advances and the next 50 years of cardiology.
|
|
Academic Article
|
2016 Revision of the SCAI position statement on public reporting.
|
|
Academic Article
|
American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee).
|
|
Academic Article
|
Do major cardiovascular outcomes in patients with stable ischemic heart disease in the clinical outcomes utilizing revascularization and aggressive drug evaluation trial differ by healthcare system?
|
|
Academic Article
|
Role of Big Data in Cardiovascular Research.
|
|
Academic Article
|
Hospital resource utilization during coronary artery bypass surgery.
|
|
Academic Article
|
The changing healthcare market and how it has influenced the treatment of cardiovascular disease--Part 1.
|
|
Academic Article
|
Cost-effectiveness of clopidogrel in acute coronary syndromes in Canada: a long-term analysis based on the CURE trial.
|
|
Academic Article
|
Cost and cost-effectiveness studies in heart failure research.
|
|
Academic Article
|
Clinical outcomes and economic impact of the 2017 ACC/AHA guidelines on hypertension in China.
|
|
Academic Article
|
Challenges in Risk Adjustment for Hospital and Provider Outcomes Assessment.
|
|
Academic Article
|
A collaborative program for cardiovascular patient follow-up.
|
|
Academic Article
|
The cost-effectiveness of the use of clopidogrel in acute coronary syndromes in five countries based upon the CURE study.
|
|
Academic Article
|
Development of 2 registry-based risk models suitable for characterizing hospital performance on 30-day all-cause mortality rates among patients undergoing percutaneous coronary intervention.
|
|
Academic Article
|
Is a paradigm shift in US healthcare reimbursement inevitable?
|
|
Academic Article
|
Cost of Cardiovascular Disease Event and Cardiovascular Disease Treatment-Related Complication Hospitalizations in the United States.
|
|
Academic Article
|
Prediction scores after myocardial infarction: value, limitations, and future directions.
|
|
Academic Article
|
Reduce Acute Care Costs, and All Other Healthcare Costs Too.
|
|
Academic Article
|
Cost effectiveness of eplerenone in patients with heart failure after acute myocardial infarction who were taking both ACE inhibitors and beta-blockers: subanalysis of the EPHESUS.
|
|
Academic Article
|
Methods for the economic and quality of life supplement to the cilostazol for RESTenosis (CREST) trial.
|
|
Academic Article
|
Cost-effectiveness of medical, endovascular and surgical management of peripheral vascular disease.
|
|
Academic Article
|
The impact of age on outcomes after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: one-year results from the Stent or Surgery (SoS) trial.
|
|
Academic Article
|
Usefulness of the substitution of nonangiographic end points (death, acute myocardial infarction, coronary bypass and/or repeat angioplasty) for follow-up coronary angiography in evaluating the success of coronary angioplasty in patients with angina pectoris.
|
|
Academic Article
|
Addressing Health Care Disparities.
|
|
Academic Article
|
The economic burden of hypertriglyceridemia among US adults with diabetes or atherosclerotic cardiovascular disease on statin therapy.
|
|
Academic Article
|
Volume as a surrogate for percutaneous coronary intervention quality: is this the right measuring stick?
|
|
Academic Article
|
Value in Healthcare Initiative: Summary and Key Recommendations.
|
|
Academic Article
|
Economic analysis of a transesophageal echocardiography-guided approach to cardioversion of patients with atrial fibrillation: the ACUTE economic data at eight weeks.
|
|
Academic Article
|
Quantitative results of baseline angiography and percutaneous coronary intervention in the COURAGE trial.
|
|
Academic Article
|
Is an invasive interventional strategy of value in non-ST-elevation acute coronary syndromes?
|
|
Academic Article
|
ACCF/AHA 2011 key data elements and definitions of a base cardiovascular vocabulary for electronic health records: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards.
|
|
Academic Article
|
Relation of operator volume and experience to procedural outcome of percutaneous coronary revascularization at hospitals with high interventional volumes.
|
|
Academic Article
|
Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes.
|
|
Academic Article
|
Acceptance, panic, and partial recovery the pattern of usage of drug-eluting stents after introduction in the U.S. (a report from the American College of Cardiology/National Cardiovascular Data Registry).
|
|
Academic Article
|
A comparison of self-selectivity corrections in economic evaluations and outcomes research.
|
|
Academic Article
|
The Role of National Registries in Improving Quality of Care and Outcomes for Cardiovascular Disease.
|
|
Academic Article
|
Cost-effectiveness of eplerenone compared with placebo in patients with myocardial infarction complicated by left ventricular dysfunction and heart failure.
|
|
Academic Article
|
The National Cardiovascular Data Registry Voluntary Public Reporting Program: An Interim Report From the NCDR Public Reporting Advisory Group.
|
|
Grant
|
Patient Level Prediction of Clinical Outcomes and Cost-Effectiveness in SPRINT (Optimize-SPRINT)
|
|
Grant
|
ACCF-STS Database Collaboration on the Comparative Effectiveness of PCI and CABG
|
|
Academic Article
|
A longitudinal assessment of coronary interventional program quality: a report from the American College of Cardiology-National Cardiovascular Data Registry.
|